Aspecte clinico-biologice şi imunologice la pacienţii cu ciroză hepatică de etiologie virală aflaţi sub tratament cu Imupurin şi Imuheptin
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
1493 11
Ultima descărcare din IBN:
2024-02-28 02:24
SM ISO690:2012
TCACIUC, Eugen, CIUHRII, Veaceslav. Aspecte clinico-biologice şi imunologice la pacienţii cu ciroză hepatică de etiologie virală aflaţi sub tratament cu Imupurin şi Imuheptin. In: Arta Medica , 2014, nr. 1(52), pp. 55-57. ISSN 1810-1852.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Arta Medica
Numărul 1(52) / 2014 / ISSN 1810-1852 /ISSNe 1810-1879

Aspecte clinico-biologice şi imunologice la pacienţii cu ciroză hepatică de etiologie virală aflaţi sub tratament cu Imupurin şi Imuheptin


Pag. 55-57

Tcaciuc Eugen, Ciuhrii Veaceslav
 
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“
 
 
Disponibil în IBN: 6 aprilie 2015


Rezumat

The purpose of this study was to examine the evolution of clinical, biochemical and immunological parameters in patients with liver cirrhosis under the influence of treatment with Imuheptin and Imupurin. After 3 months of treatment was found complete regression or decrease of clinical signs and syndroms: dyspepsic and astenovegetativ syndroms. The positive evolution of clinical signs was confirmed by results of laboratory investigations. Decrease of ALT activity in all monitored patients were found and decrease of CIC. During the study all patients established good tolerability of the administered medication.

The purpose of this study was to examine the evolution of clinical, biochemical and immunological parameters in patients with liver cirrhosis under the influence of treatment with Imuheptin and Imupurin. After 3 months of treatment was found complete regression or decrease of clinical signs and syndroms: dyspepsic and astenovegetativ syndroms. The positive evolution of clinical signs was confirmed by results of laboratory investigations. Decrease of ALT activity in all monitored patients were found and decrease of CIC. During the study all patients established good tolerability of the administered medication.

Cuvinte-cheie
ciroza, Tratament,

imupurin,

Imuheptin.